article · Future Medicinal Chemistry
<b>Aim:</b> This study focuses on advancing green chemistry in anticancer drug discovery, particularly through the synthesis of azine derivatives with a naphthalene core using CS-SO<sub>3</sub>H as a catalyst. <b>Methods:</b> Novel benzaldazine and ketazine derivatives were synthesized using (<i>E</i>)-(naphthalen-1-ylmethylene)hydrazine and various carbonyl compounds. The methods employed included thermal and grinding techniques, utilizing CS-SO<sub>3</sub>H as an eco-friendly and cost-effective catalyst. <b>Results:</b> The approach resulted in high yields, short reaction times and demonstrated catalyst reusability. Cytotoxicity tests highlighted compounds <b>3b, 11</b> and <b>13</b> as potent against the HEPG2-1. <b>Conclusion:</b> This study successfully aligns with the objectives of eco-conscious drug development in organic chemistry. Molecular docking and <i>in silico</i> studies further indicate the potential of these ligands as antitumor medicines, with favorable oral bioavailability properties.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4155/fmc-2023-0351
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.